CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Curanex Pharmaceuticals Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$4.92+0.30 (+6.49%)
Close on Oct 19, 2026
- Market cap
- $139.55M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Curanex Pharmaceuticals has not reported a dividend
No dividend per share appears in Curanex Pharmaceuticals's annual filings since fiscal 2023.